Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Eli
Lilly Wins Evista Patent Ruling in Teva Case 2:27 PM 9/24/2009
Bloomberg
Eli Lilly & Co won a ruling that its patents for its Evista (raloxifene) osteoporosis
treatment are valid. It blocks Teva Pharmaceutical Industries from selling a generic version of the bone-loss
drug. Provides protection for Evista through March of 2014.
...
Wyeth
denied order to block rival's generic drug 1:27 PM 9/24/2009
The Associated Press
Federal judge rejects Wyeth's request for a temporary
restraining order to block Orchid Chemicals & Pharmaceuticals Ltd from selling a generic version of Zosyn.
...
Drug
May Slow Down Parkinson's Disease 10:10 AM 9/24/2009
ABC News
Final results from a trial of the drug Azilect (rasagiline) in Parkinson's cases
suggest the drug may slow patient deterioration. Some experts voiced doubts.
...
Cephalon
sleep drug wins fast review for jet lag 8:35 AM 9/24/2009
Reuters
The US FDA will review Cephalon Inc's Nuvigil sleep disorder drug on a priority basis
for an additional use of treating excessive sleepiness tied to jet lag.
...
Chelsea's
hypotension drug fails trial, shares plunge 7:37 AM 9/24/2009
Reuters
Shares of Chelsea Therapeutics lost about three-quarters of their value
after the company said its experimental drug to treat neurological disorder missed the main goal of a late-stage
study.
...
Cancer
Vaccine Shows Improved Results With Vical Additive 5:28 AM 9/24/2009
Wall Street Journal
Vical Inc said an animal trial of a cancer vaccine formulated
with Vaxfectin adjuvant proved effective.
...
Lilly
patents upheld by US court in Teva dispute 5:07 AM 9/24/2009
MarketWatch
Eli Lilly & Co said that a federal court upheld its method-of-use patents on Evista
(raloxifene) for osteoporosis in postmenopausal women. The patents protect Evista through March 2014.
...
For
First Time, AIDS Vaccine Shows Some Success in
Trials 3:43 AM 9/24/2009
New York
Times
Vaccine RV 144 in over 16,000 volunteers was 31.2 percent effective. Researchers want to figure
out which response was effective and direct research from there.
...
Keryx
kidney drug shows positive long-term data 5:15 PM 9/23/2009
Reuters
Keryx Biopharmaceuticals Inc said its drug candidate Zerenex was well
tolerated and safe in a mid-stage study testing long-term use in patients with end-stage renal disease.
...
Injectable
vaccine better than intranasal for seasonal flu in
adults 3:35 PM 9/23/2009
Los Angeles
Times
Injectable vaccines containing inactivated viruses prevent about 50% more seasonal flu in
healthy adults than the intranasal vaccine containing a weakened virus.
...
CTI
pulls EU application for lung drug Opaxio 12:37 PM 9/23/2009
Reuters
Cell Therapeutics has withdrawn its European marketing application for its
lung drug Opaxio after concerns were raised by European officials over how the clinical trials were designed.
...
Wyeth
Sues FDA Seeking To Reverse Zosyn Approval 11:04 AM 9/23/2009
Wall Street Journal
Wyeth claims the generic piperacillin/tazobactam product can't be safely
used due to interactivity with an intravenous solution used in conjunction with Zosyn.
...
Cancer
drug Erbitux extends life in one study 6:36 AM 9/23/2009
Reuters
Colon cancer drug Erbitux from Merck KGaA, Eli Lilly, and Bristol-Myers Squibb extends
survival significantly in patients with a certain genetic profile.
...
Nektar's
cancer drug shows promise in early trial 4:44 AM 9/23/2009
Reuters
Nektar Therapeutics said its experimental ovarian cancer compound showed
encouraging results in an early stage study. Nektar licensed two drugs using the technology to AstraZeneca.
...
US
FDA staff see potential to abuse Covidien drug 9:29 AM 9/22/2009
Reuters
Neuromed Pharmaceuticals and Covidien's Exalgo experimental longer-lasting
opioid pain drug is prone to abuse and overdose as it can easily be crushed by biting the tablet.
...
<- Day Earlier | Today's News
|
